NASDAQ:AXON

Axon Enterprise (AXON) Q2 2026 Earnings: Revenue Growth & Margins

Font: Financial Modeling Prep  • Aug 04, 2026

Market Chart

Axon Enterprise (NASDAQ: AXON) Q2 2026 Earnings Preview: Revenue Growth Amid Margin Pressures

  • Analysts expect strong revenue growth for Axon Enterprise, fueled by demand for products such as TASER 10 and its software services.
  • Despite the anticipated revenue increase, profit margins may remain under pressure because of acquisition-integration costs, employee compensation, and other operating expenses.
  • Analysts forecast revenue of approximately $876.42 million and earnings per share (EPS) of around $1.89, which would represent a potential decline from the prior-year quarter.

Axon Enterprise (NASDAQ: AXON) develops and sells law-enforcement technology, including TASER devices, body cameras, and digital evidence software. The company is scheduled to release its quarterly earnings report on August 5, 2026, after the market closes. The report will provide insight into its recent financial performance and growth.

Wall Street analysts project Axon Enterprise’s revenue at approximately $876.42 million for the quarter. The Zacks Consensus Estimate is slightly lower at approximately $868.00 million. The consensus estimate would represent revenue growth of roughly 29.7% compared with the same period last year.

The expected revenue growth is supported by demand for Axon Enterprise’s products, including the TASER 10 device and software services. The company may also benefit from its acquisition of Carbyne, which expanded its presence in emergency-response technology.

Analysts estimate EPS at approximately $1.84, while the Zacks Consensus Estimate is $1.89. The consensus estimate would represent a 10.9% decline from the prior-year quarter, according to Zacks Investment Research.

Despite expected revenue growth, Axon Enterprise may continue to face pressure on its profit margins. Rising acquisition-integration costs, employee wages, and stock-based compensation could weigh on overall profitability.

Market Overview
ENSC
Ensysce Biosciences, Inc.
$0.52
44.83%
SURG
SurgePays, Inc.
$0.33
45.48%
CELZ
Creative Medical Technology Holdings, Inc.
$1.15
71.95%
SPCX
Space Exploration Technologies Corp.
$114.92
6.14%
GAUZ
Gauzy Ltd. Ordinary Shares
$0.43
69.53%
ONFO
Onfolio Holdings, Inc.
$0.06
-17.36%
HTZ
Hertz Global Holdings, Inc.
$2.02
29.49%
NVDA
NVIDIA Corporation
$218.99
-0.10%
UWMC
UWM Holdings Corporation
$1.20
-34.78%
SOUN
SoundHound AI, Inc.
$7.08
10.11%